Search This Blog

Tuesday, October 22, 2019

Biogen EPS beats by $0.90, beats on revenue

Biogen (NASDAQ:BIIB): Q3 Non-GAAP EPS of $9.17 beats by $0.90; GAAP EPS of $8.39 beats by $0.61.
Revenue of $3.6B (+5.0% Y/Y) beats by $70M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.